Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Burning Rock Biotech Stock Price, Quotes and Forecasts | NASDAQ:BNR | Benzinga

Q: What sector and industry does Burning Rock Biotech (BNR) operate in?

Burning Rock Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Burning Rock Biotech stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BNR.

Open	-
Close	-
Volume / Avg.	259.00 / 6.39K
Day Range	- - -
52 Wk Range	2.62 - 8.99
Market Cap	$62.68M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	0.06%
Days to Cover	13.37

Recent News

Why Aehr Test Systems Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Sinking Burning Rock Faces De-Listing. But Could Privatization Bid Come First?

Key Takeaways: Burning Rock announced its shares could be delisted due to prolonged trading below the required $1 threshold The cancer detection specialist’s former biggest revenue source tumbled 40.6% in the third quarter amid an industry crackdown, spotlighting a major risk for Chinese companies By Doug Young

The Bamboo Works

New Horizon Health Finds Formula For Profits Ahead Of Schedule

Key Takeaways: New Horizon Health posted a 61.3 million yuan adjusted profit in the first half of 2023, benefiting from soaring revenue for its three approved products The company sees big growth potential for its home-based cervical cancer screening product By Molly Wen

The Bamboo Works

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	-
Close	-
Volume / Avg.	259.00 / 6.39K
Day Range	- - -
52 Wk Range	2.62 - 8.99
Market Cap	$62.68M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	0.06%
Days to Cover	13.37

About Burning Rock Biotech Ltd

Sector

Health Care

Industry

Biotechnology

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Burning Rock Biotech (BNR) stock?

You can purchase shares of Burning Rock Biotech (NASDAQ:BNR) through any online brokerage.

View our list of the best stock brokerages

Who are Burning Rock Biotech (BNR) competitors?

Other companies in Burning Rock Biotech’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Gain Therapeutics (NASDAQ:GANX), Inozyme Pharma (NASDAQ:INZY), Immuneering (NASDAQ:IMRX) and PepGen (NASDAQ:PEPG).

What is the forecast, or price target, for Burning Rock Biotech (BNR) stock?

There is no analysis for Burning Rock Biotech to provide a consensus price target.

What is the current price for Burning Rock Biotech (BNR)?

The stock price for Burning Rock Biotech (NASDAQ: BNR) is $6.11 last updated February 7, 2025 at 7:49 AM EST.

Does Burning Rock Biotech (BNR) pay a dividend?

There are no upcoming dividends for Burning Rock Biotech.

When is Burning Rock Biotech (NASDAQ:BNR) reporting earnings?

Burning Rock Biotech’s Q1 earnings are confirmed for Wednesday, May 28, 2025.

Is Burning Rock Biotech (BNR) going to split?

There is no upcoming split for Burning Rock Biotech.

What sector and industry does Burning Rock Biotech (BNR) operate in?

Burning Rock Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Burning Rock Biotech Stock Price, Quotes and Forecasts

Burning Rock Biotech (BNR) Forecast